Pharmaceutical companies acquire innovation through purchases of biotechnology companies, joint ventures, acquisition of patents, etc., in an investment effort that is progressively diminishing the relevance of their internal R & D efforts.
In this session, major pharmaceutical companies will share with the audience their criteria when seeking new investment opportunities and their preferred models of collaboration with the biotech industry.
María Jesús Fernández García: Director of Finance & Investor Relations, INVEST IN SPAIN (Spain)